+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vascular Graft Market by Product Type, Blood Vessel Diameter, Indication, End User, Distribution Channel - Global Forecast 2026-2032- Product Image
Vascular Graft Market by Product Type, Blood Vessel Diameter, Indication, End User, Distribution Channel - Global Forecast 2026-2032- Product Image
Sale

Vascular Graft Market by Product Type, Blood Vessel Diameter, Indication, End User, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4986094
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Vascular Graft Market is projected to reach USD 1.90 Billion in 2026. It is expected to continue growing at a CAGR of 6.44%, reaching USD 2.78 Billion by 2032.

The vascular graft market is advancing as cardiovascular disease, peripheral artery disease, aortic aneurysm repair, diabetes-related vascular complications, and end-stage kidney disease continue to drive demand for durable vascular access and bypass solutions. The World Health Organization identifies cardiovascular disease as the world’s leading cause of death, while the International Diabetes Federation and kidney disease literature report expanding diabetes and chronic kidney disease burdens that increase the population requiring hemodialysis access, revascularization, and complex vascular reconstruction.

Market momentum is supported by the clinical use of synthetic vascular grafts such as expanded polytetrafluoroethylene (ePTFE), polyester/Dacron grafts, and increasingly sophisticated biologic and tissue-engineered alternatives. Hospitals, ambulatory surgical centers, vascular surgery departments, and dialysis access centers are prioritizing vascular graft devices that improve patency, reduce infection risk, support minimally invasive procedures, and lower reintervention rates. As healthcare systems focus on value-based outcomes, vascular graft innovation is shifting from product availability toward evidence-backed performance, procedural efficiency, and long-term patient benefit.

Transformative Shifts in the Vascular Graft Landscape

The vascular graft landscape is being reshaped by the convergence of endovascular therapy, hybrid operating rooms, advanced biomaterials, and rising demand for patient-specific treatment pathways. Traditional open surgical bypass remains essential for many complex vascular reconstruction cases, yet the growth of endovascular aneurysm repair, peripheral vascular intervention, and hybrid repair strategies is changing product requirements across graft flexibility, sealing performance, kink resistance, suture retention, and compatibility with imaging-guided workflows.

Material science is another decisive shift. Manufacturers are developing vascular grafts with improved thromboresistance, antimicrobial properties, bioactive surfaces, and better tissue integration to address complications such as thrombosis, stenosis, pseudoaneurysm formation, and surgical site infection. At the same time, procurement teams are demanding clinical evidence, total-cost-of-care justification, and supply resilience. These shifts favor organizations that combine regulatory discipline, surgeon education, robust post-market surveillance, and scalable manufacturing with differentiated vascular graft technology.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence the vascular graft ecosystem across diagnosis, procedural planning, manufacturing quality control, and post-operative monitoring. AI-enabled imaging analytics can support assessment of vessel diameter, calcification, lesion morphology, aneurysm anatomy, flow dynamics, and access-site suitability, helping clinicians select graft types and plan interventions with greater consistency. In dialysis access and peripheral bypass, predictive models may help identify patients at higher risk of graft failure, stenosis, infection, or repeat intervention.

For manufacturers, AI can strengthen design optimization, simulation-driven prototyping, defect detection, process validation, and supply planning. Machine learning models can analyze real-world evidence from registries, electronic health records, imaging repositories, and claims data to evaluate vascular graft durability and complication trends. While adoption depends on data quality, regulatory acceptance, cybersecurity, interoperability, and clinician trust, AI is expected to improve decision support and lifecycle management rather than replace vascular specialists.

Key Regional Insights

North America remains a leading vascular graft market due to high procedure volumes, established reimbursement systems, advanced vascular surgery infrastructure, and strong adoption of endovascular and hybrid interventions. The United States drives regional demand through its large cardiovascular disease burden, sizeable dialysis population, and concentration of medical device innovation, while Canada emphasizes evidence-based procurement, universal healthcare access, and specialized vascular care pathways.

Europe benefits from mature hospital networks, strong clinical research activity, and regulatory oversight under the EU Medical Device Regulation, with Germany, France, Italy, Spain, and the United Kingdom supporting demand through vascular reconstruction, dialysis access, peripheral artery disease treatment, and aneurysm repair. Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN markets invest in hospital capacity, cardiovascular care, chronic disease management, and access to advanced vascular graft devices.

Latin America, led by Brazil and Mexico, is gaining traction as public and private systems expand vascular intervention capabilities and dialysis infrastructure. The Middle East, particularly GCC countries, is investing in tertiary hospitals, specialty care, and chronic disease programs in response to high diabetes and cardiovascular risk factors. Africa shows longer-term potential as cardiovascular diagnosis, dialysis access, surgical infrastructure, and urban referral systems improve, although affordability, workforce availability, and procurement consistency remain important constraints.

Key Group Insights

The G7 represents a high-value vascular graft demand base because of aging populations, strong reimbursement pathways, mature vascular surgery capacity, advanced dialysis networks, and extensive use of innovative graft technologies. The European Union adds regulatory harmonization and cross-border clinical evidence generation, although Medical Device Regulation compliance has increased documentation, clinical evaluation, and post-market surveillance requirements for manufacturers.

BRICS countries are increasingly important as China, India, Brazil, Russia, and South Africa expand cardiovascular treatment capacity, dialysis access, and localized medical device production. ASEAN markets offer growth through rising healthcare expenditure, medical tourism hubs, and expanding renal care networks, particularly in major urban centers. GCC countries are investing in specialty hospitals and chronic disease management as diabetes, obesity, and cardiovascular risk factors remain public health priorities.

NATO member markets overlap significantly with high-income North American and European systems, supporting demand for resilient medical supply chains, quality assurance, and standardized procurement expectations for critical medical devices. Across these groups, winning strategies depend on regulatory agility, local partnerships, surgeon training, affordability, supply continuity, and credible real-world evidence demonstrating vascular graft safety, patency, and long-term clinical value.

Key Country Insights

The United States is the largest country-level opportunity, supported by high vascular procedure volumes, a substantial dialysis population, advanced reimbursement mechanisms, and strong adoption of premium medical technologies. Canada maintains steady demand through publicly funded healthcare and specialist vascular centers, while Mexico and Brazil are expanding access through mixed public-private healthcare systems, increasing cardiovascular intervention capacity, and growing demand for dialysis access solutions.

In Europe, Germany leads through advanced hospital infrastructure, high procedural capability, and medical technology adoption; France, Italy, and Spain sustain demand through established vascular care pathways and aging populations; and the United Kingdom emphasizes clinical evidence, health technology assessment, and National Health Service procurement discipline. Russia presents demand tied to cardiovascular disease burden and surgical need, although market access can be affected by geopolitical, reimbursement, and supply-chain constraints.

China and India offer major long-term growth potential due to large patient populations, rising diabetes and cardiovascular disease prevalence, and expanding hospital investment. Japan and South Korea remain innovation-oriented vascular graft markets with high quality expectations, sophisticated surgical practice, and strong clinical standards. Australia supports demand through advanced vascular services, clinical guidelines, specialist referral networks, and robust medical device regulation.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated vascular graft performance supported by clinical endpoints such as primary patency, assisted patency, secondary patency, infection reduction, limb salvage, reintervention rates, and patient survival. Investment in antimicrobial coatings, heparin-bonded surfaces, bioengineered grafts, tissue-engineered vascular grafts, and small-diameter graft innovation can address persistent unmet needs in peripheral bypass and dialysis access.

Organizations should strengthen real-world evidence programs, registry participation, and health economic studies to support value-based purchasing and clinical adoption. Regional strategies should combine global quality standards with local reimbursement intelligence, clinician education, and resilient distribution. Manufacturers should also prepare for stricter regulatory scrutiny by maintaining robust post-market surveillance, product traceability, clinical documentation, and transparent risk management.

To capture emerging-market growth, leaders should develop tiered portfolios, local partnerships, and training programs that support safe adoption and appropriate patient selection. AI-enabled planning tools, digital follow-up, imaging analytics, and predictive monitoring of dialysis access can further differentiate offerings when integrated responsibly into vascular care workflows and supported by validated clinical evidence.

Research Methodology

This executive summary is based on a structured secondary research approach aligned with established standards for market intelligence. Inputs include publicly available information from health authorities, regulatory agencies, peer-reviewed clinical literature, medical device guidance, disease-burden datasets, hospital care trends, and product-category disclosures. The analysis emphasizes verified indicators such as cardiovascular disease prevalence, diabetes and chronic kidney disease trends, dialysis access requirements, vascular procedure demand, regulatory developments, and technology adoption patterns.

The methodology applies triangulation across demand-side and supply-side evidence, including clinical use cases, product categories, end-user settings, regional healthcare infrastructure, reimbursement dynamics, and competitive innovation signals. Qualitative insights were assessed for consistency across sources and interpreted through an industry framework covering product performance, market access, manufacturing scalability, regulatory readiness, and patient outcomes. No unsupported market-size claims are used; the focus is on evidence-backed drivers, restraints, and strategic implications.

Conclusion

The vascular graft market is positioned for sustained strategic importance as healthcare systems address rising cardiovascular disease, dialysis access needs, peripheral artery disease, and aneurysm repair. Demand will be shaped not only by procedure volumes but also by clinical evidence, device durability, infection prevention, graft patency, procedural efficiency, and the ability to reduce repeat interventions.

Future leadership will favor organizations that integrate advanced biomaterials, surgeon-centered design, AI-enabled insights, rigorous quality systems, and region-specific access strategies. Mature markets will continue to demand proven performance and regulatory rigor, while emerging markets will reward affordability, training, and reliable supply. As vascular care becomes more data-driven and outcomes-focused, the most competitive vascular graft strategies will be those that align innovation with measurable patient and system-level value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Vascular Graft Market, by Product Type
7.1. Biological Vascular Grafts
7.1.1. Allografts
7.1.2. Autografts
7.1.3. Xenografts
7.2. Synthetic Vascular Grafts
7.2.1. Polyester
7.2.2. Polytetrafluoroethylene
7.2.3. Polyurethane
8. Vascular Graft Market, by Blood Vessel Diameter
8.1. Large
8.2. Small
9. Vascular Graft Market, by Indication
9.1. Aortoiliac Bypass Surgery
9.2. Cerebral Artery Bypass Surgery
9.3. Coronary Artery Bypass Surgery
9.4. Lower Extremity Bypass Surgery
9.5. Peripheral Artery Bypass Surgery
9.6. Renal Artery Bypass Surgery
10. Vascular Graft Market, by End User
10.1. Ambulatory Surgical Centers
10.2. Hospitals & Clinics
11. Vascular Graft Market, by Distribution Channel
11.1. Offline
11.2. Online
12. Asia-Pacific Vascular Graft Market
13. North America Vascular Graft Market
14. Latin America Vascular Graft Market
15. Europe Vascular Graft Market
16. Middle East Vascular Graft Market
17. Africa Vascular Graft Market
18. ASEAN Vascular Graft Market
19. GCC Vascular Graft Market
20. European Union Vascular Graft Market
21. BRICS Vascular Graft Market
22. G7 Vascular Graft Market
23. NATO Vascular Graft Market
24. United States Vascular Graft Market
25. Canada Vascular Graft Market
26. Mexico Vascular Graft Market
27. Brazil Vascular Graft Market
28. United Kingdom Vascular Graft Market
29. Germany Vascular Graft Market
30. France Vascular Graft Market
31. Russia Vascular Graft Market
32. Italy Vascular Graft Market
33. Spain Vascular Graft Market
34. China Vascular Graft Market
35. India Vascular Graft Market
36. Japan Vascular Graft Market
37. Australia Vascular Graft Market
38. South Korea Vascular Graft Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Abbott Laboratories
40.2. Affluent Medical
40.3. B. Braun Melsungen AG
40.4. Becton, Dickinson and Company
40.5. BIOVIC Sdn. Bhd.
40.6. Boston Scientific Corporation
40.7. Cardinal Health Inc.
40.8. Cook Medical, Inc.
40.9. Corcym S.r.l.
40.10. CryoLife, Inc.
40.11. Endologix Inc.
40.12. Getinge AB
40.13. Heart Medical Europe B.V.
40.14. Japan Lifeline Co., Ltd.
40.15. Lemaitre Vascular, Inc.
40.16. Medtronic PLC
40.17. Merit Medical Systems, Inc.
40.18. Rua Life Sciences PLC
40.19. Shanghai Suokang Medical Implants Co. Ltd.
40.20. Terumo Corporation
40.21. Vascular Graft Solutions Ltd.
40.22. VUP Medical
40.23. Vygon SAS
40.24. W. L. Gore & Associates, Inc.
40.25. Xeltis B.V.
List of Figures
FIGURE 1. GLOBAL VASCULAR GRAFT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VASCULAR GRAFT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VASCULAR GRAFT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VASCULAR GRAFT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 23. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA VASCULAR GRAFT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO VASCULAR GRAFT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CANADA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. MEXICO VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. BRAZIL VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. SPAIN VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CHINA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. INDIA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. JAPAN VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL VASCULAR GRAFT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICAL VASCULAR GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICAL VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICAL VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ALLOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ALLOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL AUTOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AUTOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AUTOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL XENOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL XENOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL XENOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SYNTHETIC VASCULAR GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SYNTHETIC VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SYNTHETIC VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL POLYESTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL POLYESTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL POLYESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL POLYTETRAFLUOROETHYLENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL POLYTETRAFLUOROETHYLENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL POLYTETRAFLUOROETHYLENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL POLYURETHANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL POLYURETHANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL LARGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL LARGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL LARGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SMALL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SMALL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SMALL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AORTOILIAC BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL AORTOILIAC BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL AORTOILIAC BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CEREBRAL ARTERY BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CEREBRAL ARTERY BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CEREBRAL ARTERY BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CORONARY ARTERY BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CORONARY ARTERY BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CORONARY ARTERY BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL LOWER EXTREMITY BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL LOWER EXTREMITY BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL LOWER EXTREMITY BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PERIPHERAL ARTERY BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PERIPHERAL ARTERY BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PERIPHERAL ARTERY BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RENAL ARTERY BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RENAL ARTERY BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL RENAL ARTERY BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. EUROPE VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 99. EUROPE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 100. EUROPE VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 101. EUROPE VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 102. EUROPE VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 103. EUROPE VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. EUROPE VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. AFRICA VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 116. AFRICA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 117. AFRICA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 118. AFRICA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 119. AFRICA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. AFRICA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. ASEAN VASCULAR GRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. ASEAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. ASEAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 124. ASEAN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 125. ASEAN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 126. ASEAN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 127. ASEAN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. ASEAN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. GCC VASCULAR GRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GCC VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. GCC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 132. GCC VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 133. GCC VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 134. GCC VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 135. GCC VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. GCC VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. BRICS VASCULAR GRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. BRICS VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 147. BRICS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 148. BRICS VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 149. BRICS VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 150. BRICS VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 151. BRICS VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. BRICS VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 153. G7 VASCULAR GRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. G7 VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. G7 VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 156. G7 VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 157. G7 VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 158. G7 VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 159. G7 VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. G7 VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. NATO VASCULAR GRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. NATO VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. NATO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 164. NATO VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 165. NATO VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 166. NATO VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 167. NATO VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. NATO VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 177. CANADA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 178. CANADA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 179. CANADA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 180. CANADA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 181. CANADA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 182. CANADA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 183. CANADA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. CANADA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. MEXICO VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 186. MEXICO VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 187. MEXICO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 188. MEXICO VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 189. MEXICO VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 190. MEXICO VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 191. MEXICO VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. MEXICO VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. BRAZIL VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 194. BRAZIL VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 195. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 196. BRAZIL VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 197. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 198. BRAZIL VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 199. BRAZIL VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. BRAZIL VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 201. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 202. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 203. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 204. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 205. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 206. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 207. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 209. GERMANY VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 210. GERMANY VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 211. GERMANY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 212. GERMANY VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 213. GERMANY VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 214. GERMANY VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 215. GERMANY VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. GERMANY VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. FRANCE VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. FRANCE VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. FRANCE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 220. FRANCE VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 221. FRANCE VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 222. FRANCE VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 223. FRANCE VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. FRANCE VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 225. RUSSIA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 226. RUSSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 227. RUSSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 228. RUSSIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 229. RUSSIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 230. RUSSIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 231. RUSSIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. RUSSIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 233. ITALY VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 234. ITALY VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 235. ITALY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 236. ITALY VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 237. ITALY VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 238. ITALY VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 239. ITALY VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. ITALY VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 241. SPAIN VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 242. SPAIN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 243. SPAIN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 244. SPAIN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 245. SPAIN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 246. SPAIN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 247. SPAIN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. SPAIN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 249. CHINA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 250. CHINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 251. CHINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 252. CHINA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 253. CHINA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 254. CHINA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 255. CHINA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. CHINA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 257. INDIA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 258. INDIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 259. INDIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 260. INDIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 261. INDIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 262. INDIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 263. INDIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 264. INDIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 265. JAPAN VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 266. JAPAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 267. JAPAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 268. JAPAN VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 269. JAPAN VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 270. JAPAN VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 271. JAPAN VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. JAPAN VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 273. AUSTRALIA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 274. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 275. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 276. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 277. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 278. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 279. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 281. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 282. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 283. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 284. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY SYNTHETIC VASCULAR GRAFTS, 2018-2032 (USD MILLION)
TABLE 285. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BLOOD VESSEL DIAMETER, 2018-2032 (USD MILLION)
TABLE 286. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 287. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 288. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Vascular Graft market report include:
  • Abbott Laboratories
  • Affluent Medical
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOVIC Sdn. Bhd.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical, Inc.
  • Corcym S.r.l.
  • CryoLife, Inc.
  • Endologix Inc.
  • Getinge AB
  • Heart Medical Europe B.V.
  • Japan Lifeline Co., Ltd.
  • Lemaitre Vascular, Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Rua Life Sciences PLC
  • Shanghai Suokang Medical Implants Co. Ltd.
  • Terumo Corporation
  • Vascular Graft Solutions Ltd.
  • VUP Medical
  • Vygon SAS
  • W. L. Gore & Associates, Inc.
  • Xeltis B.V.

Table Information

Report AttributeDetails
No. of Pages194
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.9 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.78 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Small Diameter Vascular Graft Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Small Diameter Vascular Graft Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 190 Pages
  • Global
From
Vascular Grafts Market Report 2026 - Product Image

Vascular Grafts Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Hemodialysis Vascular Grafts - Global Strategic Business Report - Product Image

Hemodialysis Vascular Grafts - Global Strategic Business Report

  • Report
  • 180 Pages
  • Global
From
Vascular Grafts - Global Strategic Business Report - Product Image

Vascular Grafts - Global Strategic Business Report

  • Report
  • 481 Pages
  • Global
From
Hemodialysis Vascular Grafts Market Report and Forecast 2025-2034 - Product Image

Hemodialysis Vascular Grafts Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From

About the Vascular Graft Market

The Vascular Graft market is a subset of the Cardiovascular Drugs market, which focuses on the development and sale of medical devices used to treat vascular diseases. Vascular grafts are artificial tubes made of synthetic materials, such as polyester, that are used to replace or bypass damaged or blocked blood vessels. These grafts are used to treat a variety of conditions, including peripheral artery disease, aortic aneurysms, and carotid artery disease. Vascular grafts are typically implanted during a surgical procedure, and are designed to be durable and long-lasting. They are also designed to be biocompatible, meaning they are not rejected by the body. The Vascular Graft market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Medtronic, W.L. Gore & Associates, C.R. Bard, Cook Medical, and Endologix. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.